Respiratory imaging is rapidly evolving beyond traditional visual assessment. With experience supporting 150+ respiratory clinical trials and 25+ pulmonary therapy approvals, Voiant combines specialized pulmonary expertise, advanced quantitative imaging, and strategic technology partnerships to help sponsors better characterize lung disease progression and treatment response. Leveraging Voiant Hub 2.0 and ReadReady™, we support advanced respiratory imaging assessments, quantitative imaging endpoints, seamless biomarker integration, and HRCT analysis while accelerating delivery of high-quality imaging endpoints.
Respiratory Imaging Capabilities
What's inside:
Specialized Pulmonary Imaging Expertise
Expert thoracic radiologists, pulmonologists, imaging scientists, and breath hold training programs supporting high-quality respiratory imaging acquisition and review
Advanced Respiratory Imaging Assessments
QILD, QLF, airway analytics, lobe segmentation, and advanced biomarkers for respiratory endpoint evaluation
Voiant Hub 2.0 & ReadReady™ for Respiratory
AI-powered image flow optimization, rapid turnaround times, and real-time site feedback supporting confident clinical development decisions
Fill out the form below to download now:
"*" indicates required fields